Patent assignee · US · COMPANY

Sprectrum Pharmaceuticals, Inc.

1Patents
0Active
1Granted
20Portfolio score

Filing activity: Dec 1, 2004 → Dec 1, 2004

Most-cited patents

PatentTitleAreaCited byStatus
US7531670B2 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives Chemistry; Metallurgy 6 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.